Literature DB >> 21057544

p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response.

L Song1, M Gao, W Dong, M Hu, J Li, X Shi, Y Hao, Y Li, C Huang.   

Abstract

Inducible acetylation of p53 at lysine residues has a great impact on regulating the transactivation of this protein, which is associated with cell growth arrest and/or apoptosis under various stress conditions. However, the factor(s) for regulating p53 acetylation remains largely unknown. In the current study, we have shown that p85α, the regulatory subunit of phosphatidylinositol-3-kinase, has a critical role in mediating p53 acetylation and promoter-specific transactivation in the ultraviolet B (UVB) response. Depletion of p85α in mouse embryonic fibroblasts significantly impairs UVB-induced apoptosis, as well as p53 transactivation and acetylation at Lys370 (Lys373 of human p53); however, the accumulation, nuclear translocation and phosphorylation of p53 are not affected. Interestingly, p85α binds to p300, promotes the p300-p53 interaction and the subsequent recruitment of the p53/p300 complex to the promoter region of the specific p53 target gene in response to UVB irradiation. Moreover, ablation of p53 acetylation at Lys370 by site-directed mutagenesis dramatically suppresses UVB-induced expression of the specific p53-responsive gene as well as cell apoptosis. Therefore, we conclude that p85α is a novel regulator of p53-mediated response under certain stress conditions, and targeting the p85α-dependent p53 pathway may be promising for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057544      PMCID: PMC3761396          DOI: 10.1038/onc.2010.506

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo.

Authors:  Julia K Kurash; Hong Lei; Qiong Shen; Wendy L Marston; Brian W Granda; Hong Fan; Daniel Wall; En Li; François Gaudet
Journal:  Mol Cell       Date:  2008-02-15       Impact factor: 17.970

2.  HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.

Authors:  Toru Sasaki; Eugene C Gan; Andrew Wakeham; Sally Kornbluth; Tak W Mak; Hitoshi Okada
Journal:  Genes Dev       Date:  2007-04-01       Impact factor: 11.361

3.  p53 Activation: a case against Sir.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

4.  Negative regulation of the deacetylase SIRT1 by DBC1.

Authors:  Wenhui Zhao; Jan-Philipp Kruse; Yi Tang; Sung Yun Jung; Jun Qin; Wei Gu
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

5.  Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.

Authors:  Eun-Joo Kim; Jeong-Hoon Kho; Moo-Rim Kang; Soo-Jong Um
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

Review 6.  How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

Authors:  A Olsson; C Manzl; A Strasser; A Villunger
Journal:  Cell Death Differ       Date:  2007-07-13       Impact factor: 15.828

7.  Skp2 suppresses p53-dependent apoptosis by inhibiting p300.

Authors:  Mayumi Kitagawa; Sang Hyun Lee; Frank McCormick
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

Review 8.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

Authors:  Sonia Lain; Jonathan J Hollick; Johanna Campbell; Oliver D Staples; Maureen Higgins; Mustapha Aoubala; Anna McCarthy; Virginia Appleyard; Karen E Murray; Lee Baker; Alastair Thompson; Joanne Mathers; Stephen J Holland; Michael J R Stark; Georgia Pass; Julie Woods; David P Lane; Nicholas J Westwood
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

10.  Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit.

Authors:  Nabil Miled; Ying Yan; Wai-Ching Hon; Olga Perisic; Marketa Zvelebil; Yuval Inbar; Dina Schneidman-Duhovny; Haim J Wolfson; Jonathan M Backer; Roger L Williams
Journal:  Science       Date:  2007-07-13       Impact factor: 47.728

View more
  16 in total

1.  Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein.

Authors:  Ying-Chih Wang; Xuan Yang; Wen-Bin Wei; Xiao-Lin Xu
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

2.  New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer.

Authors:  Xiaohui Hua; Jiheng Xu; Xu Deng; Jiawei Xu; Jingxia Li; David Q Zhu; Junlan Zhu; Honglei Jin; Zhongxian Tian; Haishan Huang; Qin-Shi Zhao; Chuanshu Huang
Journal:  Cancer Lett       Date:  2018-08-16       Impact factor: 8.679

3.  Epithelial PIK3R1 (p85) and TP53 Regulate Survivin Expression during Adaptation to Ileocecal Resection.

Authors:  Valeria Cohran; Elizabeth Managlia; Emily M Bradford; Tatiana Goretsky; Ting Li; Rebecca B Katzman; Paul Cheresh; Jeffrey B Brown; Jennifer Hawkins; Shirley X L Liu; Isabelle G De Plaen; Jörn-Hendrik Weitkamp; Michael Helmrath; Zheng Zhang; Terrence A Barrett
Journal:  Am J Pathol       Date:  2016-05-06       Impact factor: 4.307

4.  The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein XIAP.

Authors:  Yong Fang; Yonghui Yu; Qi Hou; Xiao Zheng; Min Zhang; Dongyun Zhang; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

5.  BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity.

Authors:  Yu-Hsin Chiu; Jennifer Y Lee; Lewis C Cantley
Journal:  Mol Cell       Date:  2014-03-20       Impact factor: 17.970

6.  Identification of druggable targets for radiation mitigation using a small interfering RNA screening assay.

Authors:  Crystal D Zellefrow; Elizabeth R Sharlow; Michael W Epperly; Celeste E Reese; Tongying Shun; Ana Lira; Joel S Greenberger; John S Lazo
Journal:  Radiat Res       Date:  2012-07-02       Impact factor: 2.841

7.  Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.

Authors:  Yong Fang; Zipeng Cao; Qi Hou; Chen Ma; Chunsuo Yao; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2013-05-30       Impact factor: 6.261

8.  IKKα contributes to UVB-induced VEGF expression by regulating AP-1 transactivation.

Authors:  Wen Dong; Yi Li; Ming Gao; Meiru Hu; Xiaoguang Li; Sanyue Mai; Ning Guo; Shengtao Yuan; Lun Song
Journal:  Nucleic Acids Res       Date:  2011-12-14       Impact factor: 16.971

9.  Ribosomal protein S7 regulates arsenite-induced GADD45α expression by attenuating MDM2-mediated GADD45α ubiquitination and degradation.

Authors:  Ming Gao; Xiaoguang Li; Wen Dong; Rui Jin; Hanghang Ma; Pingxun Yang; Meiru Hu; Yi Li; Yi Hao; Shengtao Yuan; Junjian Huang; Lun Song
Journal:  Nucleic Acids Res       Date:  2013-04-05       Impact factor: 16.971

10.  GSK3β signaling is involved in ultraviolet B-induced activation of autophagy in epidermal cells.

Authors:  Yang Yang; Haiping Wang; Siying Wang; Mei Xu; Mei Liu; Mingjun Liao; Jacqueline A Frank; Sabal Adhikari; Kimberly A Bower; Xianglin Shi; Cuiling Ma; Jia Luo
Journal:  Int J Oncol       Date:  2012-09-05       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.